Diabetes rates in South Africa are anticipated to keep rising in the coming years as the country’s health burden slowly shifts away from infectious diseases such as HIV and tuberculosis toward non-communicable diseases. The relevant government strategy sets three key diabetes targets. Elri Voigt spoke to several local experts about these targets and South Africa’s prospects of meeting them.
So far this year the National Institute for Communicable Diseases has issued reports on three different outbreaks of vaccine-preventable diseases – measles, mumps, and diphtheria. Elri Voigt spoke to local experts about these outbreaks and what it tells us about the country’s immunisation programme and the potential for future outbreaks.
Professor Soraya Seedat is a distinguished professor and head of Stellenbosch University’s psychiatry department. She has penned several hundreds of peer-reviewed journal articles and book chapters on psychiatric disorders, with a focus on PTSD and anxiety, particularly among children and in resource-constrained settings. Biénne Huisman sat down with her to talk about her work, what drives her, and maintaining a work-life equilibrium.
Obesity is a complicated public health issue that can be devastating on both the societal and the individual level. New weight loss medicines have shown remarkable efficacy in clinical trials, but their high cost is limiting uptake. Amy Green asks where these new medicines should fit into South Africa’s response to rising levels of obesity.
Top South African HIV clinicians are setting their sights on different approaches to finding an HIV vaccine after the “disappointing” news that the Mosaico trial was stopped early because the vaccine did not show any efficacy. The search for an HIV jab now seems set to pivot from vaccines that induce T-cell immunity to ones that induce B-cell immunity. Adele Baleta unpacks what that means and the reasoning behind it.
Falling ill with tuberculosis (TB) can be challenging for anyone, but it can be especially hard if you are pregnant or have just given birth. Globally, TB is amongst the top five causes of death in women of childbearing age. Tiyese Jeranji spoke to experts about the risks, challenges, and ongoing studies on maternal TB.
When Professor Petro Terblanche joined biotechnology start-up Afrigen three years ago, she had no idea that the team she was heading up would create the continent’s first mRNA vaccine. But that wasn’t the first time Terblanche had been at the forefront of cutting-edge scientific work. Aisha Abdool Karim spoke to her as part of Spotlight’s Women in Health series.
The benefits of approved COVID-19 vaccines still far outweigh the risks, experts say following a recently reported death in South Africa linked to Johnson & Johnson’s COVID-19 vaccine. Adele Baleta reports.
Over the last three decades, Dr Fareed Abdullah has been at the coalface of South Africa’s response to HIV, tuberculosis, and more recently, COVID-19. Biénne Huisman chatted with Abdullah about providing antiretrovirals in the time of AIDS denialism, National Health Insurance, working as a medical doctor, and the toll HIV has sadly taken on his own family.
It is estimated that around half of medical negligence claims against the South African government are cerebral palsy-type claims. Apart from the direct impact on infants and families, cerebral palsy thus also has a major impact on health budgets. In this second article in a two-part series, Elri Voigt asks what can be done to reduce the incidence of cerebral palsy in the country. In part 1 we looked at what we know about cerebral palsy in South Africa.
Respiratory Syncytial Virus (RSV) is estimated to affect 64 million people and claim around 160 000 lives around the world every year. Infants are most vulnerable and there is no effective treatment or vaccine. Tiyese Jeranji asks what we know about RSV in South Africa.
COVID began to hit South Africa badly in May 2020. Now, we are very likely beyond the worst with fewer people dying but COVID remains very infectious and rather deadly, writes Nathan Geffen and Marcus Low.
